Previous studies have demonstrated that SKP2 promotes Akt K63-mediated ubiquitination, enhancing the interaction between Akt and HK2, leading to increased cisplatin resistance in NPC [29]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.